Combination of radiotherapy and razoxane (ICRF 159) for chondrosarcoma
- 1 September 1979
- Vol. 44 (3) , 891-895
- https://doi.org/10.1002/1097-0142(197909)44:3<891::aid-cncr2820440315>3.0.co;2-r
Abstract
Eight patients with 12 chondrosarcomas were treated with radiation and razoxane (ICRF 159). Two tumors in 1 patient progressed unequivocally, 3 tumors in 3 patients showed no change, and 7 tumors in 5 patients had complete or partial (more than 50%) regressions. At least 2 complete regressions have responded for more than 2 1/2 years at the present time.This publication has 11 references indexed in Scilit:
- A clinical evaluation of ICRF 159 as a radiosensitising agentInternational Journal of Radiation Oncology*Biology*Physics, 1978
- Radiotherapy combined with ICRF 159 (NSC 129943)International Journal of Radiation Oncology*Biology*Physics, 1978
- Comparison of radiotherapy with and without razoxane (icrf 159) in the treatment of soft tissue sarcomasCancer, 1978
- RadiosensitizersPublished by S. Karger AG ,1977
- Changes in sensitivity to radiation and ICRF 159 during the life of monolayer cultures of EMT6 tumour lineBritish Journal of Cancer, 1977
- Adriamycin: Activity in Solid TumorsPublished by Springer Nature ,1975
- Strahlentherapie und ICRF 159 (NSC 129943) in der Behandlung inoperabler WeichteilsarkomeDeutsche Medizinische Wochenschrift (1946), 1974
- Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159Cancer, 1974
- Combined treatment of the Walker tumour with radiotherapy and ICRF 159Zeitschrift für Krebsforschung und Klinische Onkologie, 1974
- Chondrosarcoma of the Pelvis and Upper End of the FemurJournal of Bone and Joint Surgery, 1972